Patient Safety in India — World Patient Safety Day (Sept 17, 2025)

Context

  • Global issue: 1 in 10 patients harmed during hospitalisation; 4 in 10 in outpatient care.
  • India’s challenge:
    • Shift to chronic diseases (cancer, diabetes, CVDs, mental health).
    • Acute care risks from multi-speciality coordination failures.
    • Vulnerability to hospital-acquired infections, unsafe injections, blood transfusions, prescription errors, delayed diagnosis, preventable falls.

Causes of Patient Harm in India

  1. Systemic gaps: weak protocols, poor audits, breakdown of safety systems.
  2. Provider burden: staff shortages, fatigue, attrition, heavy workloads.
  3. Patient passivity: lack of awareness, hesitancy to question doctors.
  4. Resource gaps: <5% hospitals accredited by NABH → low compliance with global safety standards.

Current Framework & Initiatives

  • National Patient Safety Implementation Framework (2018–25):
    • Roadmap for adverse event reporting, embedding safety into clinical programs.
  • NABH Accreditation:
    • Infection control, patient rights, medication management standards.
  • Professional networks: Society of Pharmacovigilance → tracks adverse drug reactions.
  • Civil society efforts:
    • Patient Safety & Access Initiative (medical devices regulation clarity).
    • Patients for Patient Safety Foundation (reaches 14 lakh households weekly, equips 1,100 hospitals & 52,000 professionals).

Global Models & Learnings

  • WHO Global Patient Safety Action Plan: Blueprint for safety integration.
  • Patient Advisory Councils (PACs):
    • Bring patient voice into hospital decision-making.
    • Improve trust, safety, communication (proven in high-income countries).

Way Forward

  1. Policy & Governance:
    • Renew commitment beyond 2025 framework.
    • Mobilise resources for patient safety programs.
    • Integrate safety modules into medical & nursing education.
  2. Hospitals & Providers:
    • Adopt NABH standards at scale.
    • Establish PACs for patient engagement.
    • Co-develop digital safety tools (flagging harmful drug interactions, aiding communication).
  3. Community & Civil Society:
    • Patients & families to maintain records, report adverse events, avoid self-medication.
    • Media to highlight failures and best practices.
    • Corporates to support safety campaigns via CSR.
  4. Technology:
    • AI-driven drug safety alerts.
    • Telemedicine protocols for safe chronic care.
    • Digital patient records for error prevention

 

Leave a Reply

Your email address will not be published. Required fields are marked *